NCT05355389

Brief Summary

The primary goal of this project is providing evidence that a home-based combined cognitive-motor training program improves cognition in persons with multiple sclerosis (MS), compared to single cognitive and motor rehabilitation. Secondary goals are to assess the effects on walking performance and to identify the mechanisms of improvement and predictors of treatment response. The main backbone of this project will be a randomized controlled two-centre clinical trial, in which an at-home computerised cognitive-motor rehabilitation program using telemedicine aimed at improving working memory in persons with MS will be evaluated. Based on the information gathered during this trial, possible mechanisms of improvement will be identified by analysing anatomical and neurophysiological changes on structural MRI and resting-state and task-related EEG before and after rehabilitation. Furthermore, factors that can predict treatment response to the rehabilitation program will be identified.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P75+ for not_applicable multiple-sclerosis

Timeline
13mo left

Started Sep 2022

Longer than P75 for not_applicable multiple-sclerosis

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Sep 2022May 2027

First Submitted

Initial submission to the registry

April 14, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 2, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2027

Last Updated

April 2, 2025

Status Verified

March 1, 2025

Enrollment Period

4.7 years

First QC Date

April 14, 2022

Last Update Submit

March 27, 2025

Conditions

Keywords

multiple sclerosiscognitive rehabilitationcognitive-motor rehabilitationtelerehabilitation

Outcome Measures

Primary Outcomes (1)

  • Change in Digit span backwards

    Measure of working memory

    0 weeks, 12 weeks, 24 weeks, 64 weeks

Secondary Outcomes (14)

  • Change in Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)

    0 weeks, 12 weeks, 24 weeks, 64 weeks

  • Change in Corsi backwards

    0 weeks, 12 weeks, 24 weeks, 64 weeks

  • Change in Expanded Disability Status Scale (EDSS)

    0 weeks, 12 weeks, 24 weeks, 64 weeks

  • Change in 6-Minute Walk Test (6MWT)

    0 weeks, 12 weeks, 24 weeks, 64 weeks

  • Change in 25-Foot Walk Test (25FWT)

    0 weeks, 12 weeks, 24 weeks, 64 weeks

  • +9 more secondary outcomes

Other Outcomes (8)

  • Change in Hospital Anxiety and Depression Scale (HADS)

    0 weeks, 12 weeks, 24 weeks, 64 weeks

  • Change in Fatigue Scale for Motor and Cognitive functions (FSMC)

    0 weeks, 12 weeks, 24 weeks, 64 weeks

  • Change in Visual Analogue Scale (VAS)

    0 weeks, 12 weeks, 24 weeks, 64 weeks

  • +5 more other outcomes

Study Arms (3)

Cognitive-motor training group

EXPERIMENTAL
Behavioral: Cognitive trainingBehavioral: Motor training

Cognitive training group

ACTIVE COMPARATOR
Behavioral: Cognitive training

Motor training group

ACTIVE COMPARATOR
Behavioral: Motor training

Interventions

For the cognitive treatment intervention the widely used cognitive training program RehaCom will be used. This is a computer-aided program with more than 30 modules focusing on different domains of cognition. RehaCom has shown improvements in verbal learning, visuospatial memory, information processing speed, attention, executive functions, depression, fatigue and quality of life in PwMS (PMID 31927200, 28116167, 19825502, 23192417). Patients will train on their home computer without direct therapist supervision, using three RehaCom modules that are focused on improving working memory. Both patients in the combined intervention and the cognitive intervention group will be doing a 45-minute computer session respectively one and two days per week for a total of 12 weeks.

Also known as: BrainStim
Cognitive training groupCognitive-motor training group
Motor trainingBEHAVIORAL

For the motor treatment intervention a patient-tailored aerobic training program will be used. Based on their baseline physical activity level patients can choose out of a number of aerobic activities of either mild, moderate or strenuous intensity, with a total training time of 90 minutes for the motor intervention group and 45 minutes for the combined intervention group, divided over at least two training sessions per week of at least 15 minutes per session. The training will be carried out individually at home, without therapist supervision. All physical activities will be logged using the sport watch equipped with a heart rate sensor and an accelerometer. Training intensity will be assessed using the patient's heart rate and the Rating of Perceived Exertion scale.

Cognitive-motor training groupMotor training group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinically definite multiple sclerosis (revised McDonald criteria 2017)
  • Expanded Disability Status Scale (EDSS) below 6.0
  • Digit span backwards z-score between \[-3 and -0.5\] standard deviations below the median of the normative values
  • Age between 18 and 65
  • Able to safely perform motor rehabilitation in the home situation (assessed by rehabilitation physician and/or occupational or physiotherapist)

You may not qualify if:

  • Less than one month post-exacerbation
  • Major psychiatric or medical disorder that could influence cognitive functions
  • Combined vision with optimal correction below 0.6 on Snellen Visual Acuity Test
  • Unable or unwilling to undergo EEG or MRI
  • Refusing informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Universitair Ziekenhuis Brussel

Brussels, Belgium

RECRUITING

National MS Center Melsbroek

Melsbroek, Belgium

RECRUITING

Related Publications (1)

  • Van Laethem D, Van de Steen F, Kos D, Naeyaert M, Van Schuerbeek P, D'Haeseleer M, D'Hooghe MB, Van Schependom J, Nagels G. Cognitive-motor telerehabilitation in multiple sclerosis (CoMoTeMS): study protocol for a randomised controlled trial. Trials. 2022 Sep 14;23(1):778. doi: 10.1186/s13063-022-06697-9.

MeSH Terms

Conditions

Multiple Sclerosis

Interventions

Cognitive Training

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Neurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Guy Nagels

    Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The study will be double-blinded: patients will not be made aware of the rationale and predictions of the study. The teleconsultations will be carried out by a trained MS nurse, while the baseline and follow-up testing and analyses are carried out by an investigator who is blinded to the treatment allocation of the patients.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients will be randomly assigned to either the cognitive-motor, the cognitive or the motor telerehabilitation group, stratified by baseline activity level and cognition.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 14, 2022

First Posted

May 2, 2022

Study Start

September 1, 2022

Primary Completion (Estimated)

May 31, 2027

Study Completion (Estimated)

May 31, 2027

Last Updated

April 2, 2025

Record last verified: 2025-03

Locations